Bailard’s Diversified Healthcare Trust DHC Stock Holding History

Bailard’s Portfolio DHC Stock Details DHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-74,000	Closed	-$237K	–	708
2022 Q1	$237K	Buy	+74,000	New	+$226K	0.01%	621

Other funds holding DHC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FFL

Flat Footed LLC Wilson, Wyoming $920M AUM 86.47% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

H2CM

H/2 Credit Manager Stamford, Connecticut $500M AUM 24.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

GAMC

Garner Asset Management Corp Plano, Texas $255M AUM 22.93% 1-Year Est. Return

Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return

Bailard's DHC Position: Q2 2022 in Review

Bailard sold out of Diversified Healthcare Trust (DHC) in Q2 2022, closing a stake of 74,000 shares — an estimated $237K sold.

Bailard first reported a position in DHC in Q1 2022 and held it in 1 quarter. The position peaked at $237K in Q1 2022. 242 funds tracked by Wall St. Rank hold DHC as of Q2 2022.

Bailard reported no remaining Diversified Healthcare Trust position as of Q2 2022 after selling out during the quarter.
Bailard sold 74,000 Diversified Healthcare Trust shares in Q2 2022, an estimated $237K.
Bailard first reported a position in Diversified Healthcare Trust in Q1 2022 and held it in 1 quarter.
Bailard's Diversified Healthcare Trust position peaked at $237K in Q1 2022.
242 funds tracked by Wall St. Rank held Diversified Healthcare Trust as of Q2 2022.

Based on Bailard's 13F filing for Q2 2022, filed 27 Jul 2022.